ADHD medication associated with reduced rates of suicide, substance misuse, transport accidents and criminality in Swedish study of 148,581 people.
[read the full story...]
How safe is it to treat ADHD in people with schizophrenia spectrum disorders? New long-term data offers pragmatic reassurance, but also some warnings.
[read the full story...]
In his debut blog, Franco De Crescenzo summarises a narrative review that finds good evidence for the short-term pharmacological treatment of ADHD.
[read the full story...]
Douglas Badenoch appraises an up-to-date systematic review and decision pathway for the drug treatment of ADHD symptoms in young people with autism spectrum disorder.
Follow #CAMHScampfire on Twitter at 5pm BST on Tuesday 25th May for an online journal club discussing this paper. Or sign up now to join the free webinar hosted by ACAMH.
[read the full story...]
In her debut blog, Poppy Ellis Logan summarises a longitudinal study which finds rates of ADHD prescription increased in Ireland between 2005 and 2015.
[read the full story...]
Samuele Cortese reports on a recent study of 13-25 year old people with ADHD, which looks at the comparative risk of psychosis during treatment with methylphenidate and amphetamines.
[read the full story...]
Dean Connolly is impressed by a recent systematic review and network meta-analysis, which compares the efficacy and tolerability of medication for ADHD in children, young people and adults.
[read the full story...]
Samuele Cortese considers the findings of a recent nationwide self controlled case series study of the cardiovascular safety of methylphenidate use in children and young people with ADHD.
[read the full story...]
Samuele Cortese publishes his debut Mental Elf blog on a meta-analysis of n-of-1 trials, which shows that amphetamine derivatives and methylphenidate are superior to placebo, in the short term, for paediatric ADHD.
[read the full story...]
Chris Hollis appraises a recent Cochrane systematic review, which casts doubt over the quality of trial evidence and the clinical effectiveness of Methylphenidate for ADHD.
[read the full story...]
